chr3-186582011-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 16P and 4B. PVS1PP5_Very_StrongBS2
The NM_016306.6(DNAJB11):c.616C>T(p.Arg206*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_016306.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB11 | NM_016306.6 | c.616C>T | p.Arg206* | stop_gained | 6/10 | ENST00000265028.8 | NP_057390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB11 | ENST00000265028.8 | c.616C>T | p.Arg206* | stop_gained | 6/10 | 1 | NM_016306.6 | ENSP00000265028.3 | ||
ENSG00000283149 | ENST00000418776.1 | c.16C>T | p.Arg6* | stop_gained | 1/6 | 3 | ENSP00000408410.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250896Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135586
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461214Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726920
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74286
ClinVar
Submissions by phenotype
Polycystic kidney disease 6 with or without polycystic liver disease Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 17, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with polycystic kidney disease 6 with or without polycystic liver disease (MIM#618061). (I) 0107 - This gene is associated with autosomal dominant disease. However, there is emerging evidence of a recessive association (PMID: 33129895, PMID: 34177435). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v2, v3) <0.001 for a dominant condition (2 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported as pathogenic, and observed in individuals with DNAJB11-related kidney disease (ClinVar, PMID: 32631624). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic, and observed in multiple unrelated families with polycystic kidney disease (ClinVar, PMID: 32631624, PMID: 29706351). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | Oct 15, 2018 | This variant is interpreted as Pathogenic, for Polycystic kidney disease 6 with or without polycystic liver disease, autosomal dominant. The following ACMG Tag(s) were applied: PVS1-Strong => PVS1 downgraded in strength to Strong. PM2 => Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP1-Strong => PP1 upgraded in strength to Strong. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 27, 2018 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Diagnostics Centre, Carl Von Ossietzky University Oldenburg | Nov 04, 2024 | This change results in the formation of a premature stop codon at protein position 206. The variant affects an exon [6/10] present in a biologically relevant transcript and is predicted to cause protein truncation/absent due to nonsense mediated decay in a gene where loss-of-function is a known mechanism of disease. The variant is likely to be associated to polycystic kidney disease and has been reported in multiple unrelated individuals affected with [DNAJB11]- associated disorders (PMID: 32631624, 29706351). Segregation of the variant with the disease has been demonstrated (PMID: 29706351). This variant has been classified in four entries in ClinVar as pathogenic (ClinVar ID: 549851). This variant is classified as very rare in the overall population (MAF 3,79 * e-6 in gnomAD, v4.1.0). In summary, the variant is classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics of Inherited Kidney Disorders Laboratory, Garvan Institute of Medical Research | Jan 01, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at